Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
[5] [6] The medication carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Get Your Medical Information Ready Before meeting with a healthcare provider, gather key details like your weight, medical history, current medications, past weight loss efforts, and personal goals
These findings not only validate the clinical potential of GCG/GLP-1 dual receptor agonists, but also highlight the continued evolution of multi-target metabolic therapies in diabesity treatment
A thorough medication review is essential to identify potential drug interactions and assess the need for dose adjustments of concurrent diabetes medications to minimise hypoglycaemia risk
It says adjustments or discontinuation of existing diabetes agents may be needed before starting, and that this reconciliation should be provider-directed rather than self-managed at home
For weight management in patients with obesity, the recommended starting dose is 0.25 mg per week for the first four weeks
US$ 25.20
US$ 22.83
US$ 25.75
US$ 23.38
US$ 26.22
US$ 20.31
US$ 29.01
US$ 29.57
US$ 28.29
